TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer
Author:
Publisher
Galenos Yayinevi
Subject
Hematology
Reference20 articles.
1. 1. Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan, China. International journal of infectious diseases. 2020 Feb; 91: 264-6. doi: 10.1016/j.ijid.2020.01.009
2. 2. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The lancet. 2020 Feb; 395(10223): 507-13. doi: 10.1016/S0140-6736(20)30211-7
3. 3. Tison GH, Avram R, Kuhar P, Abreau S, Marcus GM, Pletcher MJ, et al. Worldwide effect of COVID-19 on physical activity: a descriptive study. Annals of internal medicine. 2020 Nov; 173(9): 767-70. doi: 10.7326/M20-2665
4. 4. Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military medical research. 2020 Dec; 7(1): 1-23. doi: 10.1186/s40779-020-0233-6
5. 5. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International journal of antimicrobial agents. 2020 Mar; 55(3): 105924. doi: 10.1016/j.ijantimicag.2020.105924
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging Innate Immune Cells in Cancer Immunotherapy: Promises and Challenges;BioDrugs;2024-05-03
2. Bispecific antibodies for multiple myeloma: past, present and future;International Journal of Hematology;2024-04-13
3. Thymic NK-Cells and Their Potential in Cancer Immunotherapy;ImmunoTargets and Therapy;2024-03
4. NK cell exhaustion in the tumor microenvironment;Frontiers in Immunology;2023-11-02
5. Targeting Potential of Innate Lymphoid Cells in Melanoma and Other Cancers;Pharmaceutics;2023-07-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3